Another case of intracranial pathology was observed in an earlier clinical trial for metachromatic leukodystrophy (MLD), a lysosomal disease caused by a defect in the arylsulfatase A (ARSA) gene. This evidence concerns the gene ARSA and metachromatic leukodystrophy.